Human SAN-Plexus Assembloids and Pacemaker Maturation

The human sinoatrial node (SAN) is not simply an isolated cluster of automatic cardiomyocytes. It is a three-dimensional pacemaker–conduction system whose activity is shaped by cellular heterogeneity, atrial coupling, and intrinsic cardiac neural inputs. The reference study, “Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems”, addresses a major limitation in human cardiac modeling: the lack of an in vitro system that reconstructs interactions between human pacemaker myocardium, cardiac ganglionated plexus neurons, and atrial tissue.

Study Background and Research Question

The SAN initiates the electrical impulse that drives each heartbeat, while its position and firing rate are continuously modulated by the intrinsic cardiac nervous system and the autonomic nervous system. Human SAN tissue is difficult to study directly because it is scarce, intramural, and organized into specialized regions, including head, tail, and transitional populations. Animal models have established important principles of SAN development and regulation, but species differences in electrophysiology and autonomic control complicate direct translation.

Human pluripotent stem cell (hPSC) differentiation can produce SAN-like pacemaker cells expressing characteristic developmental and functional features. However, conventional two-dimensional cultures and many cardiac organoids do not reproduce the regional organization, neural inputs, and atrial exit pathways of the human pacemaker system. The central research question was therefore whether hPSC-derived organoids could be assembled into a functional model of neuro-cardiac crosstalk and whether this platform could reveal signaling programs associated with human pacemaker maturation.

The study focuses on two linked biological problems. First, can a human SAN model generate organized pacemaker activity and conduct impulses toward atrial-like tissue? Second, do cardiac plexus-derived neurons provide instructive signals that change the molecular, structural, or electrophysiological state of SAN-like cells?

Key Innovation from the Reference Study

The principal innovation is the construction of SAN-plexus assembloids from distinct hPSC-derived tissue modules. The authors integrate SAN organoids (SANOs) with cardiac ganglionated plexus organoids (CGPOs), and then incorporate atrial-like cardiac organoids to create a tri-assembloid that models pacemaker-to-atrial conduction. This modular architecture is important because it separates tissue specification from tissue interaction: researchers can generate specialized organoids first and then examine how their contact changes function.

The platform advances beyond a pacemaker-cell culture in three ways. It introduces a three-dimensional interface between pacemaker myocardium and cardiac neurons, incorporates an atrial-like receiving compartment for studying impulse propagation, and permits functional comparison of assemblies with or without neural tissue. The result is a model of a neuro-pacemaker unit rather than a preparation containing only SAN-like cardiomyocytes.

A second innovation is the integration of human spatial transcriptomics with assembloid experiments. Spatial data from human SAN tissue provide an anatomical and molecular reference, while the assembloids supply experimental access to cell–cell interactions. This combination allowed the investigators to move from descriptive regional gene expression toward a candidate neuron-to-pacemaker signaling mechanism involving CGPO-derived prosaposin (PSAP) and the SAN-enriched receptor GPR37.

Methods and Experimental Design Insights

The experimental design uses complementary models rather than relying on a single readout. SANOs represent pacemaker myocardium, CGPOs provide intrinsic cardiac neural components, and atrial-like organoids provide a downstream conduction target. These units were integrated into SAN–plexus and tri-assembloid configurations, enabling analysis of both neural modulation and pacemaker-to-atrial coupling.

Phenotyping was performed across molecular, structural, and electrophysiological levels. Molecular analyses addressed SAN identity and maturation, including pacemaker-associated transcriptional programs and ion-channel features. Structural analyses examined the organization and interaction of the assembled compartments. Electrophysiological measurements assessed spontaneous activity and conduction behavior, allowing the platform to be evaluated as a functional pacemaker system rather than solely as a marker-defined organoid.

The mechanistic component connected spatial transcriptomic observations in human SAN tissue with functional manipulation in the assembloid system. The authors identified PSAP expression in CGPO-derived neural populations and examined its relationship with GPR37, a receptor enriched in SAN-like cells. This strategy is stronger than inferring mechanism from co-expression alone because the candidate pathway was evaluated in a reconstituted human tissue context.

Protocol Parameters

• Module specification: Establish SAN, cardiac plexus, and atrial-like organoid identities separately before assembly; this preserves the ability to verify each compartment independently.
• Assembly design: Include SAN-only, SAN–plexus, and tri-assembloid conditions when possible so that neural effects and atrial coupling can be distinguished from baseline pacemaker differentiation.
• Identity controls: Confirm pacemaker, neural, and atrial-like populations with molecular markers and morphology before interpreting changes in electrophysiology.
• Functional endpoints: Measure spontaneous activity together with impulse propagation toward atrial-like tissue; automaticity alone does not establish a physiologically relevant pacemaker–conduction unit.
• Mechanism testing: Use spatial transcriptomic evidence to prioritize candidate ligand–receptor interactions, then test those interactions experimentally rather than treating regional co-localization as proof of causality.
• Data integration: Compare assembloid molecular and electrophysiological profiles with human SAN reference data to assess biological relevance and identify maturation-associated features.

These parameters should be viewed as design principles derived from the reference study, not as a universal differentiation recipe. hPSC line, batch, organoid size, culture medium, assembly timing, and recording platform can all influence phenotype and should be reported when adapting the system.

Core Findings and Why They Matter

The SAN-plexus assembloids displayed molecular, structural, and electrophysiological features consistent with a human pacemaker system. Importantly, the tri-assembloid configuration extended the model from impulse generation to pacemaker-to-atrial conduction. This is a meaningful advance because conduction failure can result from defects in pacemaker maturation, tissue coupling, or neural regulation, and these processes are difficult to separate in simpler cultures.

The assembloids also enabled direct interrogation of neural control over SAN automaticity. In this context, neurons are not merely a source of background electrical activity. They function as a developmental and regulatory compartment that can influence the state of pacemaker cells. The work therefore supports a view of SAN maturation as an interaction-dependent process involving both myocardial specification and innervation-associated signaling.

The PSAP–GPR37 pathway is the study’s central mechanistic finding. Spatial transcriptomic analysis of human SAN tissue and functional analyses in the assembloid model converged on a signaling relationship in which CGPO-derived prosaposin engages the SAN-enriched receptor GPR37. The reported effect is promotion of SAN-like pacemaker maturation. This observation provides a testable molecular link between intrinsic cardiac neurons and pacemaker myocardium, rather than describing neuro-cardiac crosstalk only at the level of anatomy or electrophysiological correlation.

For cardiovascular research, the broader significance is methodological. The platform can be used to examine how neural inputs influence automaticity, conduction, and disease-associated dysfunction in a human genetic background. It also creates an experimental setting in which developmental signals, cell–cell interactions, and electrophysiological phenotypes can be analyzed together. That combination may be particularly useful for studying congenital SAN dysfunction, where a defect may involve pacemaker maturation or neuro-cardiac integration rather than a single ion channel.

The study also has implications for GPCR signaling research, although its principal pathway is PSAP–GPR37 rather than classical adrenergic stimulation. A defined receptor agonist or antagonist could be incorporated into future perturbation studies to separate acute modulation of pacemaker activity from longer-term maturation effects. Such experiments would need to distinguish changes in beat rate from changes in cell identity, conduction organization, and neural–myocardial signaling.

Comparison with Existing Internal Articles

The internal overview “Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids” presents the platform as a human stem cell-derived tri-assembloid model for investigating neuro-cardiac interactions. That framing is consistent with the reference study’s central contribution, particularly its emphasis on combining SAN, cardiac plexus, and atrial-like compartments.

The reference paper, however, provides a more specific evidence chain than a general platform overview. It links the assembled tissue architecture to electrophysiological function and then connects human SAN spatial data with the PSAP–GPR37 mechanism. For researchers assessing the system, this distinction matters: the platform is not valuable merely because it contains several cardiac and neural cell types; its innovation lies in testing whether those compartments produce measurable maturation and conduction phenotypes.

Limitations and Transferability

The assembloid model improves human relevance but does not reproduce the full adult heart. Organoids may contain immature or heterogeneous populations, and the proportions and regional organization of cells can vary between hPSC lines and differentiations. The cultured neural compartment also cannot capture every feature of the intact intrinsic cardiac nervous system, including long-range connectivity, vascular interactions, mechanical loading, and circulating endocrine influences.

Spatial transcriptomics strengthens anatomical interpretation, but spatial association alone cannot establish that a candidate ligand–receptor pair is sufficient or necessary in vivo. The PSAP–GPR37 result is therefore best interpreted as a mechanistically supported pathway within the assembloid model that warrants validation in additional human systems. Genetic perturbation, pathway-selective intervention, and analysis across independent cell lines would help determine how broadly the mechanism applies.

Electrophysiological transferability also requires caution. Spontaneous beating and conduction in an organoid assembly do not automatically reproduce adult SAN action-potential properties, autonomic responses, or clinical rhythm behavior. Benchmarking against human tissue remains essential, as does careful separation of acute rate modulation from durable maturation. These limitations do not diminish the platform’s value; they define the questions for which it is most appropriate: human developmental modeling, mechanism discovery, comparative perturbation, and early disease phenotyping.

Research Support Resources

For workflows that add a controlled beta-adrenergic perturbation to studies of beta-adrenergic receptor signaling, GPCR signaling, or the cAMP/PKA pathway, researchers can use Isoproterenol sulfate dihydrate (SKU C6402), also referred to as Isoproterenol hemisulfate. This non-selective beta receptor agonist is relevant to experimental cardiovascular research, but it should be treated as an optional pharmacological perturbation: the reference study’s principal maturation mechanism is the CGPO-derived PSAP–GPR37 interaction, not isoproterenol exposure.